Issue 19, 2014

Silicon nanowire-based therapeutic agents for in vivo tumor near-infrared photothermal ablation

Abstract

The first example of silicon nanowire (SiNW)-based in vivo tumor phototherapy is presented. Gold nanoparticle (AuNP)-decorated SiNWs are employed as high-performance NIR hyperthermia agents for highly efficacious in vivo tumour ablation. Significantly, the overall survival time of SiNW-treated mice is drastically prolonged, with 100% of mice being alive and tumor-free for over 8 months, which is the longest survival time ever reported for tumor-bearing mice treated with nanomaterial-based NIR hyperthermia agents.

Graphical abstract: Silicon nanowire-based therapeutic agents for in vivo tumor near-infrared photothermal ablation

Supplementary files

Article information

Article type
Paper
Submitted
16 Jan 2014
Accepted
20 Feb 2014
First published
24 Feb 2014

J. Mater. Chem. B, 2014,2, 2892-2898

Silicon nanowire-based therapeutic agents for in vivo tumor near-infrared photothermal ablation

Y. Su, F. Peng, X. Ji, Y. Lu, X. Wei, B. Chu, C. Song, Y. Zhou, X. Jiang, Y. Zhong, S. Lee and Y. He, J. Mater. Chem. B, 2014, 2, 2892 DOI: 10.1039/C4TB00100A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements